Lennart Minthon (Former)

241 – 250 of 304

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/psyk-lmi?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
24
25
26
27
…
31
next »

2007
Mark Activities of daily living - Outcome during two years in galantamine treated Alzheimer patients
Wattmo, Carina ^LU ; Wallin, Åsa ^LU and Minthon, Lennart ^LU (2007) 8th International Conference on Alzheimer`s and Parkinson`s Diseases (AD/PD 2007) p.251-255
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
Mark Effects of Alzheimer's peptide and alpha1-antichymotrypsin on astrocyte gene expression
Baker, Crystal ; Nielsen, Henrietta ^LU ; Minthon, Lennart ^LU ; Wright, HT ; Chappell, Sally ; Okyere, John ; May, Sean ; Morgan, Kevin ; Kalsheker, Noor and Janciauskiene, Sabina ^LU (2007) In Neurobiology of Aging
- Contribution to journal › Article
Mark Three-year outcome of Galantamine treatment in Alzheimer’s disease in a routine clinical setting.
Wallin, Åsa ^LU ; Wattmo, Carina ^LU and Minthon, Lennart ^LU (2007) IPA (International Psychogeriatric Association) 2007 Osaka Silver Congress
- Contribution to conference › Poster
Mark Activities of Daily Living – Outcome During Three Years in Donepezil Treated Alzheimer Patients.
Wattmo, Carina ^LU ; Wallin, Åsa ^LU and Minthon, Lennart ^LU (2007) IPA (International Psychogeriatric Association) 2007 Osaka Silver Congress
- Contribution to conference › Poster
Mark Alzheimer's disease - Safety and dropout in long-term galantamine treatment in a routine clinical setting
Wallin, Åsa ^LU ; Wattmo, Carina ^LU and Minthon, Lennart ^LU (2007) 8th International Conference on Alzheimers and Parkinsons Diseases p.245-249
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
2006
Mark Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study
Winblad, B ; Kilander, L ; Eriksson, S ; Minthon, Lennart ^LU ; Batsman, S ; Wetterholm, AL ; Jarisson-Blixt, C and Hoglund, A (2006) In The Lancet 367(9516). p.1057-1065
- Contribution to journal › Article
Mark Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
Hansson, Oskar ^LU ; Zetterberg, Henrik ; Buchhave, Peder ; Londos, Elisabet ^LU ; Blennow, Kaj and Minthon, Lennart ^LU (2006) In Lancet Neurology 5(3). p.228-234
- Contribution to journal › Article
Mark Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year.
Merrill, Charley A ; Jonsson, Michael A G ; Minthon, Lennart ^LU ; Ejnell, Hasse ; C-son Silander, Hans ; Blennow, Kaj ; Karlsson, Mats ; Nordlund, Arto ; Rolstad, Sindre and Warkentin, Siegbert ^LU , et al. (2006) In Journal of Clinical Psychiatry 67(8). p.1171-1178
- Contribution to journal › Article
Mark Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment
Darreh-Shori, T. ; Meurling, L. ; Pettersson, T. ; Hugosson, K. ; Hellstrom-Lindahl, E. ; Andreasen, N. ; Minthon, Lennart ^LU and Nordberg, A. (2006) In Journal of Neural Transmission 113(11). p.1791-1801
- Contribution to journal › Article
Mark CSF Biomarkers for Alzheimer's Disease: Levels of beta-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival.
Wallin, Åsa ^LU ; Blennow, K ; Andreasen, N and Minthon, Lennart ^LU (2006) In Dementia and Geriatric Cognitive Disorders 21(3). p.131-138
- Contribution to journal › Article

« previous
1
…
24
25
26
27
…
31
next »